Efficacy Assessment of SCENAR Device on Common Spinal Pain Syndrome (SCENAR1)

Hopital Foch

Status

Completed

Conditions

Pain Syndrome

Treatments

Device: SCENAR application with the device off

Device: SCENAR application

Study type

Interventional

Funder types

Other

Identifiers

NCT03755817

2017015F

Details and patient eligibility

About

Randomized, singled blinded, controlled trial of the efficacy of a SCENAR session in patients with vertebral pain. SCENAR is an electrotherapy device.

Enrollment

60 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Male or female over 18 and under 80 years of age
Suffering of common spinal pain: cervical pain including cervico-brachial neuralgia, lumbar pain including lumbo-radiculalgia
Having attended a "pain consultation" or referred to a pain consultant during hospitalization
Having signed the consent form
Can be contacted directly by phone if patient is not hospitalized
Be affiliated to a national insurance scheme or benefiting from such a program

Non-inclusion Criteria:

Pregnant or breast-feeding women
Patients with a pacemaker
Patients whose skin condition makes the use of SCENAR impossible (wounds, recent scars, skin infections)
Patient whose spinal pain is known to be related to inflammatory pathology (spondylarthropathy, rheumatoid arthritis, chondrocalcinosis), trauma (fractures and dislocations), tumor (metastases, myeloma localization), spondylodiscitis infectious, neurological (intrarachidian tumor or posterior fossa) or radiculalgia with deficient signs
Patients who have already had a SCENAR session
Patients who have already participated in this study